Media & Events

At 4Potentia, we’re committed to elevating ingredient science from academic insight to real-world impact. That commitment is on full display in our latest white paper, “Advancing DIM Bioavailability Through Solubilized Formulation,” published in SupplySide Supplement Journal.

This paper tackles one of the most persistent challenges in botanical formulation: improving systemic exposure of diindolylmethane (DIM) —a compound renowned for its influence on hormone metabolism, immune pathways, and cellular balance — which historically suffers from poor aqueous solubility and inconsistent absorption.

The Problem with Traditional DIM

DIM is naturally derived from cruciferous vegetables and valued for its role in estrogen and androgen pathways, detoxification support, and broader homeostatic functions. However, its potential has been limited by a fundamental pharmaceutical issue: DIM’s low solubility in water results in variable absorption and unpredictable systemic exposure. This means that even well-designed products may deliver inconsistent results if the active compound never reaches effective levels in the body.

Why Formulation Science Matters More Than Dose

The white paper underscores a critical insight: delivery technology matters at least as much as the dose itself. Through state-of-the-art pharmaceutical formulation techniques originally honed for poorly soluble drugs, researchers have turned DIM from a compound with low uptake into one with far more predictable bioavailability profiles.

Rather than relying on high dose levels to chase effects — a strategy that can exacerbate tolerability issues and increase cost —solubilized formulations focus on consistent uptake at lower functional doses, which supports both consumer experience and regulatory strategy.

What You’ll Discover Inside the White Paper

Our white paper walks through key scientific and formulation topics, including

• Mechanistic barriers to DIM absorption and why conventional crystalline forms fall short.
• Pharmaceutical precedents demonstrating how solubilized delivery systems improve bioavailability for similar compounds.
• Data-driven insights on how solubilized DIM technologies enable more consistent systemic exposure, broader formulation flexibility, and improved tolerability profiles.
• Applications for today’s product pipelines, including hormone balance, detoxification, liver health, and comprehensive wellness platforms.

From Paper to Product: Connecting the Dots to BIO-DiMaX®

The insights in this white paper laid the foundation for BIO-DiMaX®, 4Potentia’s patent-protected DIM ingredient engineered for high bioavailability and reliable performance in finished products across categories.

By harnessing lessons from solubilized delivery science —and applying them within dietary supplement-friendly technology — BIO-DiMaX® aims to set a new industry standard for DIM performance without resorting to excessive dosages or compromise in formulation design.

Why This Matters for Brands and Formulators

Today’s consumers demand products that work consistently and that can stand up to scrutiny from regulators, practitioners, and discerning users alike. This white paper doesn’t just outline a scientific problem — it provides a roadmap for achieving real improvements in both product experience and formulation success.

If your brand is exploring hormonal health, detoxification, liver support, or multi-system wellness platforms, understanding how solubilized DIM changes the narrative is an essential step toward meaningful innovation.

Cinnamon is one of the most widely used botanicals in metabolic health formulations. Yet despite its familiarity, the category remains highly variable—defined by differences in species, sourcing, processing, and compositional consistency.

As regulatory expectations increase and brands place greater emphasis on evidence-based positioning, formulators are reassessing how cinnamon ingredients are selected, specified, and supported within finished products.

Moving Beyond Tradition-Only Ingredient Selection

Many cinnamon ingredients currently used in dietary supplements are selected based on historical use rather than ingredient-specific scientific evaluation. These materials may vary significantly in polyphenol composition, botanical definition, and batch consistency—factors that can influence formulation predictability and documentation readiness.

In contrast, some cinnamon extracts have been developed with greater emphasis on characterization, standardization, and evaluation within human research settings. One such ingredient, Cinnulin PF®, was recently recognized as a Top Pick in ConsumerLab’s 2025 cinnamon supplement review, reflecting its distinct positioning within a highly commoditized category.

Why Clinical Research Matters to Formulators

For formulation teams, ingredient selection increasingly involves more than supply availability or historical precedent. Considerations now commonly include:

• Ingredient identity and specification clarity
• Reproducibility of composition
• Availability of published research
• Alignment with structure/function claim frameworks*
• Quality documentation to support regulatory review

Cinnulin PF® is supported by published human clinical research evaluating cinnamon’s role in metabolic health parameters, including support for healthy glucose metabolism and insulin function*. This research-informed approach provides formulators with additional context when developing products intended for evidence-based positioning.

Ingredient Differentiation in a Commodity-Heavy Category

Cinnamon remains one of the most familiar—but least consistently defined—botanical ingredients on the market. Variability in species selection, processing methods, and standardization can introduce formulation challenges, particularly for brands seeking consistency across production runs or long-term product lines.

Cinnulin PF® was developed with defined sourcing, processing controls, and compositional specifications intended to support batch-to-batch consistency and predictable formulation behavior.

‍

Formulation and Regulatory Considerations for Modern Brands

As consumer expectations shift toward transparency and regulatory oversight increases, ingredient documentation and compositional clarity have become central to product development decisions.

Cinnulin PF® is supported by technical documentation intended to assist with quality review, formulation planning, and labeling considerations. The ingredient is already utilized in commercially available dietary supplements, reflecting its compatibility with real-world manufacturing and compliance environments.

For formulators, this approach supports:

• Clean-label formulation strategies
• Science-informed product narratives
• Consistent ingredient specifications over time

A Broader Shift in Botanical Formulation

Recognition from third-party evaluators such as ConsumerLab reflects a broader industry movement toward botanicals that are more clearly defined, consistently produced, and supported by published research.

For brands developing next-generation metabolic health and wellness products, ingredient selection is increasingly about balancing tradition with documentation, consistency, and long-term formulation reliability. In this context, clinically studied cinnamon extracts like Cinnulin PF® represent an evolution in how familiar botanicals are evaluated and applied.

*These statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat, cure, or prevent any disease.

‍

4POTENTIA is excited to be back at SupplySide West in 2025! Catch us on October 29th and 30th at the Mandalay Bay Convention Center in Las Vegas.

‍

Explore what’s new in our ingredient lineup, and see how 4POTENTIA is shaping the future of health and wellness.

‍

Let’s build something incredible—together.

‍

We can’t wait to see you there! 💡

‍

Please stop by our booth #5089.

‍

4POTENTIA Named Cover Story in Food Business Review — Pioneering a New Era in Natural Health Ingredients

We’re proud to share a major milestone for 4POTENTIA: we are the April 2025 cover story in Food Business Review, recognized for pioneering a new era in natural health ingredients and named Health Ingredients Product of the Year 2025.

The feature highlights 4POTENTIA’s evolution, leadership vision, and unwavering commitment to clinically validated, proprietary ingredients that help brand partners compete — and consumers trust what they’re taking.

From Legacy Ingredient Supplier to Innovation Platform

Founded more than 25 years ago as IN Ingredients, the company underwent a strategic transformation in 2024, reemerging as 4POTENTIA with a renewed mission: to bridge nature and science through differentiated, evidence-based ingredients

Under the leadership of CEO Jade Beutler, whose career spans more than three decades in the natural products industry, 4POTENTIA expanded its infrastructure, intellectual property strategy, and partner-first approach — signaling far more than a rebrand. It marked a declaration of intent.

“Our ingredients are unique, novel, patented, or proprietary. This gives our brand partners a competitive edge and ensures consumers receive products they can trust.”

Built for Brands, Backed by Science

4POTENTIA operates exclusively in the B2B ingredient space, supplying branded raw materials to leading dietary supplement companies including Bluebonnet® and Orthomolecular Nutrition®

Unlike commodity ingredients, every 4POTENTIA innovation is supported by rigorous scientific validation. Today, the company’s portfolio includes:

• 26 issued patents

• 12 human clinical studies

• Extensive proprietary and third-party research packages designed to support formulation, substantiation, and commercialization

This science-first model reflects a deliberate shift away from “faith-based” supplementation toward substantiated wellness support that aligns with modern regulatory expectations.

Cinnulin PF®: A Category-Defining Ingredient

The cover story spotlights Cinnulin PF®, 4POTENTIA’s flagship cinnamon extract and the leading branded cinnamon ingredient on the market. Standardized for Type-A polymers, Cinnulin PF® supports healthy glucose metabolism, insulin function, and body composition

Its impact is reinforced by adoption from major brands such as Sam’s Club Member’s Mark® and Doctor’s Best®, and by recent recognition from ConsumerLab® as a Top Pick in cinnamon supplements — further validating its market leadership.

Looking Ahead: BIO-DiMaX™ and the Next Wave of Innovation

The article also offers a preview of what’s next for 4POTENTIA, including the upcoming launch of BIO-DiMaX™, a breakthrough DIM ingredient engineered to solve long-standing bioavailability challenges.

With a patented delivery system shown to be 58× more bioavailable than conventional DIM, BIO-DiMaX™ represents a new standard in hormonal health formulation — delivering results at lower doses with improved tolerability

“We’re not just improving bioavailability; we’re setting a new standard for what’s possible in hormonal health supplements.”

More Than Ingredients — A True Partner Model

What ultimately distinguishes 4POTENTIA is its collaborative approach. Beyond supplying ingredients, the company equips partners with evidence packages, IP protection, and strategic support to help products succeed in a crowded marketplace.

As highlighted in Food Business Review, this philosophy continues to drive growth, innovation, and long-term brand partnerships.

Read the Full Cover Story

Read the full April 2025 Food Business Review cover story featuring 4POTENTIA

We’re honored by this recognition and excited for what’s ahead as we continue to pioneer what’s next in natural health ingredients.

‍

‍

4POTENTIA will be at SupplySide West this year! Join us on October 30th and 31st at the Mandalay Bay Conventions Center in Las Vegas.

Come visit us at booth #3477 to meet our team, learn about our innovative solutions, and discover how 4POTENTIA can help power your potential.💡

Let's connect, collaborate, and explore new opportunities together!
Looking forward to seeing you there!

IN-Ingredients celebrates their 25th Anniversary with a fresh new look and feel becoming 4POTENTIA with the tagline “A Force of Nature.”

Marking this important milestone is the addition of top talent to begin this exciting new chapter.  Veteran industry executive Jade Beutler has accepted the position of CEO. He is joined by another industry veteran John Mai, Chief Business Officer.

4POTENTIA vows to bring new, novel, proprietary and patented branded raw materials to market to enhance health, happiness and wellbeing.

Original IN-Ingredients founders Tim and Gus Romero will be staying on as strategic advisors during the transition to 4POTENTIA.

Read the press release here.